lambdastatin 10 mg tabletti, kalvopäällysteinen
biokanol pharma gmbh - atorvastatinum calcicum trihydricum,atorvastatinum calcicum - tabletti, kalvopäällysteinen - 10 mg - atorvastatiini
lambdastatin 20 mg tabletti, kalvopäällysteinen
biokanol pharma gmbh - atorvastatinum calcicum trihydricum,atorvastatinum calcicum - tabletti, kalvopäällysteinen - 20 mg - atorvastatiini
lambdastatin 40 mg tabletti, kalvopäällysteinen
biokanol pharma gmbh - atorvastatinum calcicum,atorvastatinum calcicum trihydricum - tabletti, kalvopäällysteinen - 40 mg - atorvastatiini
lambdastatin 80 mg tabletti, kalvopäällysteinen
biokanol pharma gmbh - atorvastatinum calcicum,atorvastatinum calcicum trihydricum - tabletti, kalvopäällysteinen - 80 mg - atorvastatiini
victrelis
merck sharp dohme ltd - bosepreviirin - hepatiitti c, krooninen - antiviraalit systeemiseen käyttöön - victrelis on indisoitu kroonisen hepatiitti (chc) genotyyppi-1 infektio yhdessä peginterferoni alfa ja ribaviriini potilailla palkalliset maksasairaus aikuisten jotka ovat aiemmin tai jotka eivät ole aiemmin hoitoa.
tremfya
janssen-cilag international nv - guselkumab - psoriasis - immunosuppressantit - plaque psoriasis tremfya is indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy. psoriatic arthritis tremfya, alone or in combination with methotrexate (mtx), is indicated for the treatment of active psoriatic arthritis in adult patients who have had an inadequate response or who have been intolerant to a prior disease-modifying antirheumatic drug (dmard) therapy (see section 5.
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immunoseerumit ja immunoglobuliinit, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
evusheld
astrazeneca ab - tixagevimab, cilgavimab - covid-19 virus infection - prevention of covid-19.
veklury
gilead sciences ireland uc - remdesivir - covid-19 virus infection - veklury is indicated for the treatment of coronavirus disease 2019 (covid 19) in:adults and paediatric patients (at least 4 weeks of age and weighing at least 3 kg) with pneumonia requiring supplemental oxygen (low- or high-flow oxygen or other non-invasive ventilation at start of treatment)adults and paediatric patients (weighing at least 40 kg) who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19.
glimepiride lambda 3 mg tabletti
lambda therapeutic ltd - glimepiridum - tabletti - 3 mg - glimepiridi